Kintor Pharmaceutical Limited (HKG:9939)
Hong Kong
· Delayed Price · Currency is HKD 1.170
-0.040 (-3.31%)
Apr 25, 2025, 4:08 PM HKT
Kintor Pharmaceutical Revenue
In the year 2024, Kintor Pharmaceutical had annual revenue of 5.00M CNY. Kintor Pharmaceutical had revenue of 5.00M in the half year ending December 31, 2024.
Revenue
5.00M CNY
Revenue Growth
n/a
P/S Ratio
95.20
Revenue / Employee
29.76K CNY
Employees
168
Market Cap
506.57M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeiGene | 29.60B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| WuXi Biologics | 19.87B |
| Innovent Biologics | 10.03B |
| Akeso | 2.26B |
| Alibaba Health Information Technology | 31.39B |
| CSPC Pharmaceutical Group | 30.87B |